Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule

Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule

BACKGROUND: Vaccine-induced immunity against pneumococcal infection relies on the generation of high concentrations of antibody and B-cell memory. Both the 10- and the 13-valent pneumococcal conjugate vaccines (PCV-10 and PCV-13) effectively reduce disease caused by vaccine serotypes. It is unknown...

Full description

Bibliographic Details
Main Authors:	Trück, J, Mitchell, R, Jawad, S, Clutterbuck, E, Snape, M, Kelly, D, Voysey, M, Pollard, A
Format:	Journal article
Language:	English
Published:	Wolters Kluwer Health, Inc. 2016

Similar Items

Differences in immunization site pain in toddlers vaccinated with either the 10- or the 13-valent pneumococcal conjugate vaccine
by: Trück, J, et al.
Published: (2018)

The antibody response following a booster with either a 10- or 13-valent pneumococcal conjugate vaccine in toddlers primed with a 13-valent pneumococcal conjugate vaccine in early infancy.
by: Trück, J, et al.
Published: (2016)

Sex-dependent immune responses to infant vaccination: An individual participant data meta-analysis of antibody and memory B cells
by: Voysey, M, et al.
Published: (2016)

The effect of chronic cytomegalovirus infection on pneumococcal vaccine responses.
by: O'Connor, D, et al.
Published: (2014)

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.
by: Kelly, D, et al.
Published: (2009)

Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 - 17 years.
by: Mitchell, R, et al.
Published: (2013)

Pneumococcal polysaccharide vaccine efficacy and routine use of conjugate vaccines in infants: there is no need for a vaccine program in older adults at present.
by: Trück, J, et al.
Published: (2012)

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study
by: Grant A. Mackenzie, et al.
Published: (2022-01-01)

Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine.
by: Clutterbuck, E, et al.
Published: (2008)

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM197-conjugated serogroup C meningococcal polysaccharide vaccine (vol 127, pg 134, 2009)
by: Kelly, D, et al.
Published: (2011)

A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults.
by: Lazarus, R, et al.
Published: (2011)

Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells.
by: Clutterbuck, E, et al.
Published: (2012)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
by: Ruggeberg, J, et al.
Published: (2007)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants.
by: Ruggeberg, J, et al.
Published: (2007)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
by: Ruggeberg, J, et al.
Published: (2007)

Schedules for pneumococcal vaccination of preterm infants: an RCT
by: Kent, A, et al.
Published: (2016)

Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule.
by: Rodgers, G, et al.
Published: (2013)

Persistent circulation of vaccine serotypes and serotype replacement after 5 years of infant immunization with 13-valent pneumococcal conjugate vaccine in the United Kingdom
by: Kandasamy, R, et al.
Published: (2019)

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study: statistical analysis plan
by: Grant A. Mackenzie, et al.
Published: (2024-03-01)

Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial
by: Trück, J, et al.
Published: (2014)

Pneumococcal conjugate vaccines: choice of schedule and product development
by: Jin Lee
Published: (2020-07-01)

Estimation of 13-valent Pneumococcal Conjugate Vaccine Efficiency in Infants within National Immunization Schedule
by: Nikolay I. Briko, et al.
Published: (2019-09-01)

The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials
by: Voysey, M, et al.
Published: (2016)

Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trial
by: Khatami, A, et al.
Published: (2014)

Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
by: Iro, M, et al.
Published: (2015)

Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial.
by: Hamaluba, M, et al.
Published: (2015)

Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants
by: von Kries Rüdiger, et al.
Published: (2010-01-01)

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine.
by: Clutterbuck, E, et al.
Published: (2006)

Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial.
by: Johannes Trück, et al.
Published: (2014-01-01)

Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13.
by: Trück, J, et al.
Published: (2017)

No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine
by: Licciardi, P, et al.
Published: (2016)

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM197 conjugate vaccine
by: Clutterbuck, E, et al.
Published: (2006)

Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial
by: Kandasamy, R, et al.
Published: (2019)

Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
by: Hong-Yi Lee, et al.
Published: (2018-04-01)

B cell response to pneumococcal vaccines
by: Trück, J
Published: (2014)

PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children
by: Timothy J Chapman, et al.
Published: (2024-12-01)

High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.
by: O'Connor, D, et al.
Published: (2017)

Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines--exploratory analyses within a randomised controlled trial.
by: Ameneh Khatami, et al.
Published: (2014-01-01)

Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants
by: Wei Feifei, et al.
Published: (2005-11-01)

The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule.
by: Ota, M, et al.
Published: (2011)